The Swiss firm is leader in the field of dental implant systems, having units in over 100 countries and 7,000 employees. Artis Bio Tech has been operating for 15 years on the implantology wholesale market.
The Artis Bio Tech business had grown constantly and significantly over the past years. The company’s turnover doubled between 2017 and 2019, reaching RON21 million, and its profit doubled to RON6.3 million in 2019.
Straumann Group, with an annual turnover of over EUR1.4 billion, provides complete solutions for cosmetic dentistry. The business was acquired by Straumann Group, through the company Straumann Dental, established at the end of 2019. The value of the deal has not been disclosed.
“Artis is a family business, built over the past 15 years,” said Ion Nicolescu, the main shareholder in Artis.
Straumann develops and manufactures dental implants, instruments, prosthetics, tissue and bone regeneration biomaterials for use in tooth replacement and restoration, or to prevent tooth loss.
“In the first half of 2000, during a critical period for the dental services market, Straumann Group enters in Romania by establishing the local subsidiary Straumann Dental. Today, with the takeover of Artis, we reconfirm our commitment to contribute to the development of the stomatology activity in Romania,” said George Dumitrescu, country manager Straumann Dental.